The portfolio securing the Notes has an aggregate discounted receivable balance (“ADPB”) of approximately $139million as of the statistical cut off date.
The ADPB is the aggregate discounted collections associated with the Oasis 2021-1portfolio’s litigation funding receivables, litigation loan receivables (“Litigation Receivables”), medical funding receivables and medical loan receivables (“Medical Receivables” and, collectively, “Receivables”).
The discount rate used to calculate the ADPB is a percentage equal to the sum of the anticipated interest rate on the Notes, the servicing fee rate of 1.50%, and an additional 0.10%.
As of the statistical cut off date,Litigation Receivables, Medport Medical Receivables and Key Health Medical Receivables comprise approximately 36%, 58% and 6%of the aggregate funded amount and have average advance to expected case settlement values (“Expected Worth Ratio”) of 9.5%, 31.6% and 29.5%, respectively. (Kroll rating Agency)